Abstract：Objective To investigate the effects of Sacubitril and Valsartan Sodium Tablets on ventricular remodeling in patients with heart failure complicated with hyponatremia. Methods A total of 82 patients with heart failure complicated with hyponatremia who were diagnosed and treated in Huai’an First People’s Hospital Branch from March 2017 to March 2020 were selected and divided into study group and control group by random number table method, with 41 cases in each group. The control group was given Tolvaptan Tablets, while the study group was given Tolvaptan Tablets, Sacubitril and Valsartan Sodium Tablets. The therapeutic effect and drug safety of the two groups were compared. Results The total effective rate of the study group was higher than that of the control group, and the difference was statistically significant (P ＜ 0.05). After treatment, left ventricular ejection fraction (LVEF) in two groups was higher than before treatment, left ventricular end-diastolic diameter (LVEDD) and left ventricular end-systolic diameter (LVESD) were lower than those before treatment, and the differences were statistically significant (P ＜ 0.05). After treatment, the LVEDD and LVESD in the study group were lower than those in the control group, while the LVEF was higher than that in the control group, with statistically significant differences (P ＜ 0.05). After treatment, serum sodium in the two groups was higher than before treatment, and N-terminal brain natriuretic peptide precursor (NTpro-BNP) and interleukin-33 (IL-33) were lower than those before treatment, and the differences were statistically significant (P ＜ 0.05). After treatment, the sodium content in the study group was higher than that in the control group, while the levels of NTpro-BNP and IL-33 in the study group were lower than those in the control group, and the differences were statistically significant (P ＜ 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P ＞ 0.05). Conclusion Sacubitril and Valsartan Sodium Tablets in the treatment of heart failure complicated with hyponatremia can inhibit ventricular remodeling, improve the levels of hyponatremia, inflammatory factors, and neuroendocrine factors, thereby enhancing the therapeutic efficacy, with good safety.
高刻 杨君 徐华建▲. 沙库巴曲缬沙坦钠片对心力衰竭合并低钠血症患者心室重构的影响[J]. 中国医药导报, 2022, 19(11): 77-80.
GAO Ke YANG Jun XU Huajian▲. Effects of Sacubitril and Valsartan Sodium Tablets on ventricular remodeling in patients with heart failure complicated with hyponatremia#br#. 中国医药导报, 2022, 19(11): 77-80.
京公网安备 11010502046598号